To Bill or Not to Bill: TB Skin Tests Evaluations

Why This Topic Matters

TB testing is common in outpatient practice, and whether the interpretation is separately reportable affects compliance and reimbursement. Understanding the article helps practices document screening encounters appropriately and recognize the billing issues surrounding in-person versus self-reported test reads.

Article Sections

1. Billing question for TB skin test interpretation

   Introduces the reimbursement issue created when a TB skin test is placed and the results are read at a later visit. It frames the article around coding and payment considerations for the follow-up encounter.

2. Medicare and CPT guidance

   Summarizes payer and CPT-related guidance discussed in the article, including the role of face-to-face evaluation and documentation. The section also notes how the article references clinical example usage in CPT.

3. Practice perspectives and documentation tips

   Describes how some practices approach reporting the follow-up service and the documentation discussed for negative or positive test outcomes. It also addresses concerns about self-reporting and remote communication of results.

4. CDC screening guidance and patient factors

   Reviews the article’s discussion of public health guidance and the practical reasons a healthcare worker may need to interpret results. It touches on patient population considerations that can affect reliable self-reporting.